NextCell Pharma

NextCell Pharma Inventory

The Inventory of NextCell Pharma (NXTCL.ST) as of Nov 16, 2026 is 545,237.00 SEK. In the previous year, Inventory was 545,237.00 SEK — a change of 0.00% (lower).

Inventory

545,237.00SEK

YoY

0.00%

Last updated:

Inventory of NextCell Pharma is 2025 545,237.00 SEK. Inventory of NextCell Pharma was 2024 545,237.00 SEK. It decreases by 0.00% lower compared to the previous year.

The NextCell Pharma Inventory history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory
Date
Inventory
Jan 1, 2018
-1.93 M SEK
Jan 1, 2019
-2.71 M SEK
Jan 1, 2020
1.00 SEK
Jan 1, 2021
1.00 SEK
Jan 1, 2022
766,969.00 SEK
Jan 1, 2023
790,666.00 SEK
Jan 1, 2024
545,237.00 SEK
Jan 1, 2025
545,237.00 SEK
The NextCell Pharma Inventory history
YEARInventoryYoY
545,237.00SEK0.00%
545,237.00SEK-31.04%
790,666.00SEK+3.09%
766,969.00SEK+76.70 M%
1.00SEK0.00%
1.00SEK-100.00%
-2.71 MSEK+40.58%
-1.93 MSEK-192.67 M%
1.00SEK-100.00%
-592,156.00SEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

NextCell Pharma Stock analysis

What does NextCell Pharma do? NextCell Pharma AB develops stem cell therapies using a proprietary selection algorithm, focusing on autoimmune diabetes and other autoimmune diseases. The company operates a tissue establishment and biobank as a healthcare provider, commercializing mesenchymal stem cell products. Its primary revenue comes from the development and sale of these stem cell therapies to healthcare institutions and research organizations. The firm's business model centers on R&D for stem cell products, with the tissue establishment and biobank supporting its research activities. NextCell targets healthcare providers and research entities as key customers for its stem cell therapies and biobank services. NextCell Pharma AB's revenue streams are derived from the commercialization of its stem cell therapies, leveraging its proprietary technology for autoimmune disease treatment. The company's focus on mesenchymal stem cell products positions it within the healthcare provider segment, specifically serving institutions requiring advanced cell-based treatments. NextCell Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about NextCell Pharma stock

Inventory of NextCell Pharma is 545,237.00 SEK in 2025.

Inventory of NextCell Pharma changed from 545,237.00 SEK to 545,237.00 SEK, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Inventory NextCell Pharma since 2006 – with annual values, charts, and detailed analysis.

Inventory includes raw materials, work-in-progress, and finished goods. Efficient inventory management is crucial for profitability.

Inventory's SEK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Inventory's NextCell Pharma historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — NextCell Pharma

All Key Metrics — NextCell Pharma